CIK 0001681682 · Non-accelerated filer<br>Smaller reporting company
ENDRA Life Sciences Inc.
Sign in to watch- Ticker
- NDRA
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 260579295
- Phone
- 734-335-0468
- Business address
- 3600 GREEN COURT, SUITE 350, ANN ARBOR, MI, 48105
- Former names
- Endra Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-02 | DIGIANDOMENICO ANTHONY Director | Grant or award · Stock Options | +12,000 | 12,000 | ||
| 2019-12-11 | Wells David R. Chief Financial Officer | Grant or award · Stock option (right to buy) | +138,375 | 138,375 | ||
| 2019-12-11 | Wells David R. Chief Financial Officer | Grant or award · Series A Convertible Preferred Stock | +8.74 | $1,143.68 | $10K | 8.74 |
| 2019-12-11 | Wells David R. Chief Financial Officer | Grant or award · Warrants | +10,051 | 10,051 | ||
| 2019-12-11 | Tokman Alexander Y Director | Grant or award · Stock option (right to buy) | +89,585 | 89,585 | ||
| 2019-12-11 | Thornton Michael Milos Chief Technology Officer | Grant or award · Stock option (right to buy) | +575,906 | 575,906 | ||
| 2019-12-11 | Thornton Michael Milos Chief Technology Officer | Grant or award · Series A Convertible Preferred Stock | +43.72 | $1,143.68 | $50K | 43.72 |
| 2019-12-11 | Thornton Michael Milos Chief Technology Officer | Grant or award · Warrants | +50,252 | 50,252 | ||
| 2019-12-11 | Michelon Francois Roger Chief Executive Officer | Grant or award · Stock option (right to buy) | +611,994 | 611,994 | ||
| 2019-12-11 | Michelon Francois Roger Chief Executive Officer | Grant or award · Series A Convertible Preferred Stock | +4.37 | $1,143.68 | $5K | 4.37 |
| 2019-12-11 | Michelon Francois Roger Chief Executive Officer | Grant or award · Warrants | +5,026 | 5,026 | ||
| 2019-12-11 | Maloberti Renaud Bertrand Chief Commercial Officer | Grant or award · Stock option (right to buy) | +42,859 | 42,859 | ||
| 2019-12-11 | Harsh Michael Director | Grant or award · Stock option (right to buy) | +89,922 | 89,922 | ||
| 2019-12-11 | Harsh Michael Director | Grant or award · Series A Convertible Preferred Stock | +9.62 | $1,143.68 | $11K | 9.62 |
| 2019-12-11 | Harsh Michael Director | Grant or award · Warrants | +11,056 | 11,056 | ||
| 2019-12-11 | Gambhir Sanjiv Sam Director | Grant or award · Stock option (right to buy) | +89,585 | 89,585 | ||
| 2019-12-11 | DIGIANDOMENICO ANTHONY Director | Grant or award | +100,503 | $0.87 | $87K | 199,226 |
| 2019-12-11 | DIGIANDOMENICO ANTHONY Director | Grant or award · Stock option (right to buy) | +89,585 | 89,585 | ||
| 2019-12-11 | DIGIANDOMENICO ANTHONY Director | Grant or award · Warrants | +100,503 | 100,503 | ||
| 2019-09-27 | Wells David R. Chief Financial Officer | Purchase | +10,000 | $1.18 | $12K | 20,000 |
Page 7 of 11 · 207 trades